drugset / Trial / NCT01044303
Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that increased dosages of mycophenolic acid in maintenance kidney transplant recipients may cause a reduction in donor-specific antibodies.
Timeline
- Start
- 2010-01
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mycophenolic acid | Small molecule | 1440 mg | — |
| Subject | mycophenolic acid | Small molecule | 2160 mg | — |
Indications
No indication recorded.